The BJC is a unique peer-reviewed publication linking primary and secondary care. We have a registered circulation of 28,000 professional readers in print and online, as well as our active online users of 260,000. The print journal is quarterly and there are frequent online updates. Members of its prestigious editorial board lead the field of cardiometabolic medicine. The BJC is renowned for providing high quality reviews, state of the art clinical research and original papers in cardiometabolic medicine, news including global and UK congress and meeting reports, and topical podcasts. BJC Learning offers comprehensive e-learning programmes.

We reflect the changing face of medical practice and provide readers with an ideal vehicle for continuing professional development and all the elements needed to offer an enhanced service of care for patients. The BJC is proud to be entering its 23rd year of publication. The publisher, MediNews (Cardiology) Ltd, is London based and solely publishes the journal, supplements, reprints, and manages all the online publishing.

Download our media pack

Editorial Policy

We publish commissioned and submitted original clinical research and review papers. Everything is peer reviewed. Articles cover medical and interventional care of patients with cardiometabolic disorders such as:

  • hypertension
  • dyslipidaemia
  • symptomatic coronary artery disease e.g. angina pectoris
  • cardiac arrhythmias
  • heart failure

We provide rapid in-depth coverage and analysis of major cardiovascular meetings, including:

  • European Society of Cardiology
  • American Heart Association
  • American College of Cardiology
  • Interventional congresses such as TCT and PCR
  • British Cardiovascular Society
  • British Society for Heart Failure
  • Cardiorenal Forum
  • H·E·A·R·T UK
  • Scottish Heart and Arterial Risk Prevention Group
Read our instructions to authors